After Maggi, Patanjali Atta Noodles found ‘sub-standard’

  • News
  • April 15, 2016

Meerut

A team of Food Safety and Drugs Administration (FSDA) based in Meerut has found a Patanjali Atta Noodles sample “sub-standard”, with ash content in the taste maker exceeding the prescribed limits by nearly three times, even higher than Maggi samples. The tests were carried out on samples of Patanjali Noodles, Maggi and Yippee collected from Meerut on February 5, 2016, the report of which reached came out on Saturday. In all the three samples, ash content found is invariably high.The permissible limit for ash content according to law is 1%, but all the three samples failed the test and were found “substandard” for consumption.

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma recalls over 1900 bottles of epilepsy drug in US

    Sun Pharma recalls over 1900 bottles of epilepsy drug in US

    Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

    Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

    Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

    Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

    Meiji Seika to push new vaccine with SII in India

    Meiji Seika to push new vaccine with SII in India

    DGFT automates EO extension process to ease compliance for pharma exporters

    DGFT automates EO extension process to ease compliance for pharma exporters

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark